Explore News
-
FDA Opens Early Access to Daraxonrasib for 8,000 PDAC Patients
The FDA’s move to expand access to daraxonrasib offers new hope for patients with metastatic…
The FDA’s move to expand access to daraxonrasib offers new hope for patients with metastatic…
